Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities.
暂无分享,去创建一个
E. Tasheva | G. Conrad | D. Boyle | A. Koester | Gary W Conrad | Avelina Q Paulsen | A. Paulsen | Niles Fox | Elena S Tasheva | Anja Koester | Alexander S Garrett | Dan L Boyle | Harriet J Davidson | Min Song | H. Davidson | Min Song | N. Fox | Alexander S. Garrett
[1] P. Byers. Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity. , 1994, The Journal of investigative dermatology.
[2] L. Madisen,et al. Molecular cloning of a novel bone-forming compound: osteoinductive factor. , 1990, DNA and cell biology.
[3] E. Tasheva,et al. Fibroblast Growth Factor-2 Promotes Keratan Sulfate Proteoglycan Expression by Keratocytes in Vitro * , 2000, The Journal of Biological Chemistry.
[4] K. Prydz,et al. Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.
[5] Renato V. Iozzo,et al. Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.
[6] E. Thonar,et al. Altered Fine Structures of Corneal and Skeletal Keratan Sulfate and Chondroitin/Dermatan Sulfate in Macular Corneal Dystrophy* , 2001, The Journal of Biological Chemistry.
[7] Terry Magnuson,et al. Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.
[8] E. Tasheva. Analysis of the promoter region of human mimecan gene. , 2002, Biochimica et biophysica acta.
[9] J. L. Bobbitt,et al. Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors. , 1996, European journal of pharmacology.
[10] E. Tasheva,et al. Differential Splicing and Alternative Polyadenylation Generate Multiple Mimecan mRNA Transcripts* , 1997, The Journal of Biological Chemistry.
[11] J. Hassell,et al. Expression of the keratan sulfate proteoglycans lumican, keratocan and osteoglycin/mimecan during chick corneal development. , 2000, Experimental eye research.
[12] N. Burrows,et al. Ehlers-Danlos syndrome has varied molecular mechanisms. , 1997, Journal of medical genetics.
[13] J. Osbourn,et al. Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[14] F. Reinholt,et al. Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.
[15] E. Schönherr,et al. Critical Role of Glutamate in a Central Leucine-rich Repeat of Decorin for Interaction with Type I Collagen* , 1997, The Journal of Biological Chemistry.
[16] C. Kublin,et al. Proteoglycan changes during restoration of transparency in corneal scars. , 1983, Archives of biochemistry and biophysics.
[17] D. Heinegård,et al. Collagen binding proteins. , 2001, Osteoarthritis and cartilage.
[18] A. Oldberg,et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin‐deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] L. Svensson,et al. Fibromodulin and lumican bind to the same region on collagen type I fibrils , 2000, FEBS letters.
[20] J. Moreau,et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Iozzo,et al. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.
[22] M. Rudnicki,et al. Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.
[23] Oldberg,et al. Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.
[24] G. Conrad,et al. Immunoanalysis of keratan sulfate proteoglycan from corneal scars. , 1988, Investigative ophthalmology & visual science.
[25] B. Spooner,et al. Basal lamina anionic sites in the embryonic submandibular salivary gland: resolution and distribution using ruthenium red and polyethyleneimine as cationic probes. , 1986, European journal of cell biology.
[26] R. Iozzo. The Biology of the Small Leucine-rich Proteoglycans , 1999, The Journal of Biological Chemistry.
[27] K. Kimata,et al. Molecular cloning of the mouse osteoglycin-encoding gene. , 1995, Gene.
[28] E. Tasheva,et al. Mimecan, the 25-kDa Corneal Keratan Sulfate Proteoglycan, Is a Product of the Gene Producing Osteoglycin* , 1997, The Journal of Biological Chemistry.
[29] S. Saika,et al. Role of Lumican in the Corneal Epithelium during Wound Healing* , 2000, The Journal of Biological Chemistry.
[30] J. Krachmer,et al. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Tasheva,et al. Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. , 2001, Biochimica et biophysica acta.
[32] J. Hassell,et al. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.
[33] E. Tasheva,et al. Assignment1 of mimecan gene (OGN) to human chromosome band 9q22 by in situ hybridization , 2000, Cytogenetic and Genome Research.
[34] E. Tasheva,et al. The Bovine Mimecan Gene , 1999, The Journal of Biological Chemistry.